News & Updates

Endoscopic ultrasound (EUS)–guided choledocho-doudenostomy (ECDS) can be an option for primary biliary drainage in patients with unresectable malignant distal biliary obstruction (MDBO), and may be preferred when endoscopic retrograde cholangiopancreatography (ERCP) is anticipated to be difficult, according an international randomized controlled trial (RCT) led by researchers from the Chinese University of Hong Kong (CUHK).

Another HIV patient may be on the way to a cure following stem cell therapy using wild-type (WT) CCR5 donor cells for a rare and aggressive blood cancer.

Results of a systematic review and meta-analysis suggest that adding tumour-treating fields (TTFields) to standard chemoradiotherapy (CRT) significantly prolongs overall survival (OS) for patients with newly diagnosed glioblastoma multiforme (GBM) treated in the real-world setting.

New drug applications approved by US FDA as of 16-31 August 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Invasive aspergillosis and mucormycosis are two of the most common mould infections, and a growing problem worldwide, particularly amongst those who are immunocompromised. Despite recent advances in the clinical understanding of these mould infections, the mortality rate can increase significantly if these infections are left untreated. Therefore, there is a need for early diagnosis and timely therapeutic intervention. However, diagnosis remains a major challenge owing to atypical or insidious clinical presentation in patients. In this symposium, Professor Cornely shares his insights on the diagnosis and management of invasive aspergillosis and mucormycosis and his recommendations for optimising patient outcomes, including his preferred evidence-based treatment options.

At an honorary degree conferment ceremony held at the Chinese University of Hong Kong and an interview with MIMS Doctor, Professor Katalin Karikó, a pioneer of mRNA technology, suggested that recent advances in mRNA research can provide a versatile tool for combating various diseases.